Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Axonics stock | $67.42

Learn how to easily invest in Axonics stock.

Axonics Inc is a medical devices business based in the US. Axonics shares (AXNX) are listed on the NASDAQ and all prices are listed in US Dollars. Axonics employs 416 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Axonics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – AXNX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Axonics stock price (NASDAQ: AXNX)

Use our graph to track the performance of AXNX stocks over time.

Axonics shares at a glance

Information last updated 2021-10-23.
Latest market close$67.42
52-week range$41.13 - $79.81
50-day moving average $68.34
200-day moving average $63.90
Wall St. target price$78.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.70

Buy Axonics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Axonics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Axonics price performance over time

Historical closes compared with the close of $67.42 from 2021-10-22

1 week (2021-10-13) 6.95%
1 month (2021-09-24) -3.05%
3 months (2021-07-23) 1.77%
6 months (2021-04-23) 8.86%
1 year (2020-10-23) 35.00%
2 years (2019-10-24) 224.60%
3 years (2018-10-20) N/A
5 years (2016-10-20) N/A

Axonics financials

Revenue TTM $150.3 million
Gross profit TTM $67.1 million
Return on assets TTM -7.23%
Return on equity TTM -17%
Profit margin -45.36%
Book value $10.94
Market capitalisation $3.1 billion

TTM: trailing 12 months

Shorting Axonics shares

There are currently 5.0 million Axonics shares held short by investors – that's known as Axonics's "short interest". This figure is 14.7% up from 4.3 million last month.

There are a few different ways that this level of interest in shorting Axonics shares can be evaluated.

Axonics's "short interest ratio" (SIR)

Axonics's "short interest ratio" (SIR) is the quantity of Axonics shares currently shorted divided by the average quantity of Axonics shares traded daily (recently around 566562.79863481). Axonics's SIR currently stands at 8.79. In other words for every 100,000 Axonics shares traded daily on the market, roughly 8790 shares are currently held short.

However Axonics's short interest can also be evaluated against the total number of Axonics shares, or, against the total number of tradable Axonics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Axonics's short interest could be expressed as 0.11% of the outstanding shares (for every 100,000 Axonics shares in existence, roughly 110 shares are currently held short) or 0.1226% of the tradable shares (for every 100,000 tradable Axonics shares, roughly 123 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Axonics.

Find out more about how you can short Axonics stock.

Axonics share dividends

We're not expecting Axonics to pay a dividend over the next 12 months.

Axonics share price volatility

Over the last 12 months, Axonics's shares have ranged in value from as little as $41.13 up to $79.81. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Axonics's is 0.1941. This would suggest that Axonics's shares are less volatile than average (for this exchange).

Axonics overview

Axonics, Inc. , a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc.

Frequently asked questions

What percentage of Axonics is owned by insiders or institutions?
Currently 4.64% of Axonics shares are held by insiders and 113.242% by institutions.
How many people work for Axonics?
Latest data suggests 416 work at Axonics.
When does the fiscal year end for Axonics?
Axonics's fiscal year ends in December.
Where is Axonics based?
Axonics's address is: 26 Technology Drive, Irvine, CA, United States, 92618
What is Axonics's ISIN number?
Axonics's international securities identification number is: US05465P1012
What is Axonics's CUSIP number?
Axonics's Committee on Uniform Securities Identification Procedures number is: 05465P101

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site